News & Updates

Patients with treatment-resistant epilepsy appear to benefit from add-on cannabidiol, which a recent study has shown to help reduce seizure frequency for up to 192 weeks.

Use of angiotensin II (ATII)-stimulating antihypertensive medication (AHM), angiotensin receptor blockers (ARBs), and dihydropyridine calcium channel blockers (CCBs) helps reduce the risk of dementia over a decade, but this beneficial effect decreases over time, according to a study.

Individuals who have been hospitalized with infection appear to be at higher risk of dementia compared with their peers who are unexposed to infections, as reported in a study.

Teen and adult patients with drug-resistant epilepsy may benefit from modified Atkins diet, which has been shown in a recent study to produce improvements in seizure frequency, quality of life (QOL), and behavioural problems as compared with standard drug therapy.

An international team led by researchers from the Chinese University of Hong Kong (CUHK) has successfully developed world’s first artificial intelligence (AI) model that can detect Alzheimer’s disease (AD) solely through retinal photographs.